BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chaudhuri V, Nanu A, Panda SK, Chand P. Evaluation of serologic screening of blood donors in India reveals a lack of correlation between anti-HBc titer and PCR-amplified HBV DNA. Transfusion. 2003;43:1442-1448. [PMID: 14507277 DOI: 10.1046/j.1537-2995.2003.00512.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Wendel S. Rational testing for transmissible diseases. ISBT Science Series 2007;2:19-24. [DOI: 10.1111/j.1751-2824.2007.00098.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Altunay H, Kosan E, Birinci I, Aksoy A, Kirali K, Saribas S, Aslan M, Yuksel P, Alan E, Yenen OS, Kocazeybek B. Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination. Transfusion and Apheresis Science 2010;43:265-8. [DOI: 10.1016/j.transci.2010.09.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
3 Japhet MO, Adesina OA, Donbraye E, Adewumi MO. Hepatitis B core IgM antibody (anti-HBcIgM) among hepatitis B surface antigen (HBsAg) negative blood donors in Nigeria. Virol J 2011;8:513. [PMID: 22074048 DOI: 10.1186/1743-422X-8-513] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
4 Islami F, Dikshit R, Mallath MK, Jemal A. Primary liver cancer deaths and related years of life lost attributable to hepatitis B and C viruses in India. Cancer Epidemiol 2016;40:79-86. [PMID: 26683034 DOI: 10.1016/j.canep.2015.11.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
5 Seo DH, Whang DH, Song EY, Han KS. Occult hepatitis B virus infection and blood transfusion. World J Hepatol 2015;7:600-6. [PMID: 25848484 DOI: 10.4254/wjh.v7.i3.600] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
6 Gibney KB, Torresi J, Lemoh C, Biggs BA. Isolated core antibody hepatitis B in sub-Saharan African immigrants. J Med Virol 2008;80:1565-9. [PMID: 18649341 DOI: 10.1002/jmv.21267] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
7 Motta-castro ARC, Martins RMB, Araujo NM, Niel C, Facholi GB, Lago BV, Mello FCA, Gomes SA. Molecular epidemiology of hepatitis B virus in an isolated Afro-Brazilian community. Arch Virol 2008;153:2197-205. [DOI: 10.1007/s00705-008-0237-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
8 Dhawan HK, Marwaha N, Sharma RR, Chawla Y, Thakral B, Saluja K, Sharma SK, Thakur MK, Jain A. Anti-HBc screening in Indian blood donors: still an unresolved issue. World J Gastroenterol 2008;14:5327-30. [PMID: 18785287 DOI: 10.3748/wjg.14.5327] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
9 Ks M, R A, P A. The prevalence of the hepatitis B core antibody and the occult hepatitis B infection among voluntary blood donors in chennai, India. J Clin Diagn Res. 2012;6:1710-1712. [PMID: 23373034 DOI: 10.7860/jcdr/2012/4826.2636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Elghannam DM, Aly RM, Goda EF, Eltoraby EE, Farag RE. Clinical significance of antibody to hepatitis B core antigen in multitransfused hemodialysis patients. Asian J Transfus Sci 2009;3:14-7. [PMID: 20041091 DOI: 10.4103/0973-6247.45256] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
11 Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012;25:142-163. [PMID: 22232374 DOI: 10.1128/cmr.00018-11] [Cited by in Crossref: 91] [Cited by in F6Publishing: 52] [Article Influence: 10.1] [Reference Citation Analysis]
12 García-Montalvo BM, Farfán-Ale JA, Acosta-Viana KY, Puerto-Manzano FI. Hepatitis B virus DNA in blood donors with anti-HBc as a possible indicator of active hepatitis B virus infection in Yucatan, Mexico. Transfus Med. 2005;15:371-378. [PMID: 16202051 DOI: 10.1111/j.1365-3148.2005.00610.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
13 Mansoor GF, Rahmani AM, Kakar MA, Hashimy P, Abrahimi P, Scott PT, Peel SA, Rentas FJ, Todd CS. Blood supply safety in Afghanistan: a national assessment of high-volume facilities: Blood Safety in Afghanistan. Transfusion 2013;53:2061-8. [DOI: 10.1111/trf.12005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Arora S, Doda V, Kirtania T. Sensitivity of individual donor nucleic acid testing (NAT) for the detection of hepatitis B infection by studying diluted NAT yield samples. Blood Transfus. 2014;Oct 23; Epub ahead of print. [PMID: 25369612 DOI: 10.2450/2014.0048-14] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Ismail AM, Devakumar S, Anantharam R, Fletcher GJ, Subramani T, John GT, Daniel D, Abraham P. Low frequency of occult hepatitis B infection in anti-HBc seropositive blood donors: experience from a tertiary care centre in South India. Blood Transfus 2012;10:230-2. [PMID: 22153686 DOI: 10.2450/2011.0046-11] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
16 Makroo RN, Chowdhry M, Bhatia A, Arora B, Rosamma NL. Hepatitis B core antibody testing in Indian blood donors: A double-edged sword! Asian J Transfus Sci. 2012;6:10-13. [PMID: 22623835 DOI: 10.4103/0973-6247.95043] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
17 Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012;25:142-163. [PMID: 22232374 DOI: 10.1128/cmr.00018-1125/1/142] [Reference Citation Analysis]
18 Windyga J, Brojer E, Gronowska A, Grabarczyk P, Mikulska K, Szczepanik AB, Stefańska E, Buczma A. Preliminary results of HBV DNA testing of Polish haemophilia patients--lack of occult HBV infection. Haemophilia 2006;12:380-3. [PMID: 16834737 DOI: 10.1111/j.1365-2516.2006.01293.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
19 Findik D, Arslan U, Baykan M. Determination of hepatitis B virus DNA incidence, viral load, and mutations in blood donors with HBsAg and anti-HBs-negative serology and antibodies to hepatitis B core antigen. Eur J Intern Med. 2007;18:571-575. [PMID: 18054706 DOI: 10.1016/j.ejim.2007.07.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
20 Demir M, Serin E, Göktürk S, Ozturk NA, Kulaksizoglu S, Ylmaz U. The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients. Eur J Gastroenterol Hepatol. 2008;20:668-673. [PMID: 18679070 DOI: 10.1097/meg.0b013e3282f55e1e] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
21 Yilmaz S, Unlu A, Cetinkaya RA, Yapar M, Avci IY, Yilmaz S, Eyigun CP. A strategical re-thinking on National Blood Donor Pool: Anti-HBc positivity related re-entry mechanisms. Transfus Apher Sci 2016;54:271-5. [PMID: 26928919 DOI: 10.1016/j.transci.2015.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
22 El Ekiaby M, Lelie N, Allain J. Nucleic acid testing (NAT) in high prevalence–low resource settings. Biologicals 2010;38:59-64. [DOI: 10.1016/j.biologicals.2009.10.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
23 Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, Al-Bashir A. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion. 2005;45:1973-1980. [PMID: 16371052 DOI: 10.1111/j.1537-2995.2005.00635.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
24 Keechilot CS, Shenoy V, Kumar A, Biswas L, Vijayrajratnam S, Dinesh K, Nair P. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India. Pathog Glob Health 2016;110:287-91. [PMID: 27788631 DOI: 10.1080/20477724.2016.1248171] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
25 Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007;13:3730-3733. [PMID: 17659734 DOI: 10.3748/wjg.v13.i27.3730] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
26 Panigrahi R, Biswas A, Datta S, Banerjee A, Chandra PK, Mahapatra PK, Patnaik B, Chakrabarti S, Chakravarty R. Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion. Virol J. 2010;7:204. [PMID: 20799931 DOI: 10.1186/1743-422x-7-204] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
27 Liu C, Chen D, Chen P. Epidemiology of HBV infection in Asian blood donors: Emphasis on occult HBV infection and the role of NAT. Journal of Clinical Virology 2006;36:S33-44. [DOI: 10.1016/s1386-6532(06)80007-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
28 Silva CM, Costi C, Costa C, Michelon C, Oravec R, Ramos AB, Niel C, Rossetti ML. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil. J Infect 2005;51:24-9. [PMID: 15979486 DOI: 10.1016/j.jinf.2004.07.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
29 Roberts DJ, Field S, Delaney M, Bates I. Problems and Approaches for Blood Transfusion in the Developing Countries. Hematology/Oncology Clinics of North America 2016;30:477-95. [DOI: 10.1016/j.hoc.2015.11.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
30 Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion. 2007;47:74-79. [PMID: 17207233 DOI: 10.1111/j.1537-2995.2007.01066.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
31 Deng L, Xu Y, Huang J. Developing a double-antigen sandwich ELISA for effective detection of human hepatitis B core antibody. Comparative Immunology, Microbiology and Infectious Diseases 2008;31:515-26. [DOI: 10.1016/j.cimid.2007.09.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
32 Allain JP, Candotti D; ISBT HBV Safety Collaborative Group. Hepatitis B virus in transfusion medicine: still a problem? Biologicals 2012;40:180-6. [PMID: 22305086 DOI: 10.1016/j.biologicals.2011.09.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
33 Datta S, Banerjee A, Chandra PK, Chakraborty S, Basu SK, Chakravarty R. Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor. J Clin Virol 2007;40:255-8. [PMID: 17869170 DOI: 10.1016/j.jcv.2007.08.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
34 Doda V, Arora S, Kirtania T. Serological characterization of occult hepatitis B virus infection among blood donors in India. Transfus Apher Sci 2014;51:162-7. [PMID: 25131822 DOI: 10.1016/j.transci.2014.07.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
35 Chevrier MC, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay. Transfusion 2007;47:1794-802. [PMID: 17880603 DOI: 10.1111/j.1537-2995.2007.01394.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
36 Madhavan A, Sachu A, Balakrishnan AK, Balakrishnan S, Vasudevapanicker J. Prevalence of Anti-HBc Antibodies among HBsAg Negative Individuals and Its Association with Occult Hepatitis B. J Lab Physicians 2021;13:1-5. [PMID: 34054234 DOI: 10.1055/s-0041-1723046] [Reference Citation Analysis]
37 Otani K, Kasuga Y, Kimura Y, Mukaide M, Yanai H, Koyama T, Fujise K. Hepatitis B Surface Antigen Is a Better Monitor of Infectivity Compared With Antibody to Hepatitis B Core Antigen in Hemodialysis Patients: Letter to the Editor. Therapeutic Apheresis and Dialysis 2010;14:434-5. [DOI: 10.1111/j.1744-9987.2010.00829.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]